Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase. [electronic resource]
Producer: 20080729Description: 1258-66 p. digitalISSN:- 1460-2180
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Blotting, Western
- Cell Proliferation -- drug effects
- Colonic Neoplasms -- metabolism
- Gene Expression -- drug effects
- Humans
- Immunoprecipitation
- Mesalamine -- pharmacology
- Mice
- Reverse Transcriptase Polymerase Chain Reaction
- S Phase -- drug effects
- cdc25 Phosphatases -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.